MBX Biosciences Shares Are Trading Higher on Possible Continued Strength After the Company Announced Results From Its Phase 1 Single Ascending Dose and Multiple Ascending Dose Trial of MBX 1416 Yesterday.
MBX Biosciences Shares Are Trading Higher on Possible Continued Strength After the Company Announced Results From Its Phase 1 Single Ascending Dose and Multiple Ascending Dose Trial of MBX 1416 Yesterday.
MBX Biosciences的股票在公司昨天宣佈MBX 1416的第一階段單次遞增劑量和多次遞增劑量試驗結果後，可能因持續強勢而交易上漲。
MBX Biosciences Shares Are Trading Higher on Possible Continued Strength After the Company Announced Results From Its Phase 1 Single Ascending Dose and Multiple Ascending Dose Trial of MBX 1416 Yesterday.
MBX Biosciences的股票在公司昨天宣佈MBX 1416的第一階段單次遞增劑量和多次遞增劑量試驗結果後，可能因持續強勢而交易上漲。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間